Organ-on-chip & MPSconfirmed

MIMETAS

Leiden University spinout. OrganoPlate microfluidic tissue cultures in a standard plate format, plus ready-made models, instruments and contract research. About 100 employees.

Notable

Bruker took a majority stake in Aug 2026. MIMETAS keeps its brand and management.

Related deals

Aug 2026
M&A, Majority stake
Bruker took a majority stake in MIMETAS to pair organ-on-chip models with its multiomics and imaging tools.
Undisclosed
cms.law(opens in new tab)

Related updates

No related news yet.